Therapeutic Abstention and Surveillance of Intra-epithelial Histological Lesions of High Grade Cervical CIN2 (Cervical Intraepithelial Neoplasia Grade 2). SUIVICIN
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This study proposes to describe and evaluate the rate of spontaneous regression of CIN2 at 2 year of follow up in women between 18 and 39 year old. This follow-up is proposed as an alternative to the treatment of reference (conization) with a possible extension to 4 years
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:
• CIN2 confirmed by biopsy, age between 18 and 39 years,
• satisfactory colposcopy identifying the junction and the lesion,
• affiliated person or beneficiary of a social security scheme,
• having given their oral agreement and authorization to the processing of their data.
Locations
Other Locations
France
CHU Bordeaux
RECRUITING
Bordeaux
Contact Information
Primary
Jean-Luc Brun, MD, PhD
jean-luc.brun@chu-bordeaux.fr
335 56 79 59 85
Time Frame
Start Date: 2019-08-23
Estimated Completion Date: 2029-09-01
Participants
Target number of participants: 200
Treatments
CIN 2 women
Non-interventional monocentric prospective study taking place at the Bordeaux University Hospital where women with a CIN2 meeting the eligibility criteria will benefit from abstention from treatment and surveillance for at least 2 years
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Bordeaux